HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carthamin Yellow Protects the Heart Against Ischemia/Reperfusion Injury With Reduced Reactive Oxygen Species Release and Inflammatory Response.

Abstract
Carthamin yellow (CY) is a flavonoid compound isolated from safflower, which is widely used clinically in China. It has various pharmacological effects including promoting blood circulation to remove blood stasis and alleviating pain. Ischemic heart disease is one of the main culprits of illness and death. Here, in this study, ex vivo and in vivo models were used to investigate whether CY reduces ischemia/reperfusion injury. In vitro experiments further verify and explain the potential mechanisms of CY cardioprotective function. Isolated hearts from male rats with or without CY pretreatment before ischemia which underwent 30-minute ischemia followed by 60-minute reperfusion showed that CY pretreatment significantly reduced the infarct size and lactate dehydrogenase release. The in vivo experiments also indicated CY preadministration (i.v.) reduced infarct size and improved the heart function, which was impaired by myocardial ischemia/reperfusion injury. The in vitro model on myocardial cell also showed that CY reduced ischemia/reperfusion injury by reducing the lactate dehydrogenase and reactive oxygen species (ROS) releasing. Eliminating ROS with N-acetylcysteine or preinject CY into rat jugular vein reduces the expression of IL-6, TNF-a, and, especially, IL-1b in an in vivo I/R model. Also, CY pretreatment strongly reduces ischemia/reperfusion-induced NLRP3 up-expression and caspase-1 activation. Our results indicated CY reduced ischemia-reperfusion injury when administered before reperfusion. The reduction in injury is accompanied by a reduced ROS release and decreased inflammatory response.
AuthorsQi Yu Lu, Jian Qiang Ma, Yu Yin Duan, Yi Sun, Songhua Yu, Bin Li, Gui Min Zhang
JournalJournal of cardiovascular pharmacology (J Cardiovasc Pharmacol) Vol. 74 Issue 3 Pg. 228-234 (09 2019) ISSN: 1533-4023 [Electronic] United States
PMID31356540 (Publication Type: Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • Antioxidants
  • Cytokines
  • Inflammation Mediators
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Nlrp3 protein, rat
  • Reactive Oxygen Species
  • safflower yellow
  • Chalcone
  • Caspase 1
Topics
  • Animals
  • Anti-Inflammatory Agents (pharmacology)
  • Antioxidants (pharmacology)
  • Caspase 1 (metabolism)
  • Cell Hypoxia
  • Cell Line
  • Chalcone (analogs & derivatives, pharmacology)
  • Cytokines (metabolism)
  • Disease Models, Animal
  • Inflammation Mediators (metabolism)
  • Isolated Heart Preparation
  • Male
  • Myocardial Infarction (metabolism, pathology, prevention & control)
  • Myocardial Reperfusion Injury (metabolism, pathology, prevention & control)
  • Myocytes, Cardiac (drug effects, metabolism, pathology)
  • NLR Family, Pyrin Domain-Containing 3 Protein (metabolism)
  • Oxidative Stress (drug effects)
  • Rats, Wistar
  • Reactive Oxygen Species (metabolism)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: